tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ARGX Stock Latest News

Argenx’s VYVGART Shows Promising CIDP Treatment Results
Company AnnouncementsArgenx’s VYVGART Shows Promising CIDP Treatment Results
2d ago
6K
ARGX
Argenx presents data from ADHERE trial evaluating Vyvgart Hytrulo
PremiumThe Fly
Argenx presents data from ADHERE trial evaluating Vyvgart Hytrulo
2d ago
ARGX
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
PremiumPress Releases
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
2d ago
ARGX
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
8d ago
ARGX
Immunovant initiated with an Outperform at Oppenheimer
PremiumThe Fly
Immunovant initiated with an Outperform at Oppenheimer
22d ago
ARGX
IMVT
Argenx Schedules Annual Shareholders’ Meeting 2024
PremiumCompany AnnouncementsArgenx Schedules Annual Shareholders’ Meeting 2024
22d ago
6K
ARGX
Argenx Advances Promising Sjogren’s Treatment
PremiumCompany Announcements
Argenx Advances Promising Sjogren’s Treatment
22d ago
6K
ARGX
Argenx advances clinical development of efgartigimod
PremiumThe Fly
Argenx advances clinical development of efgartigimod
22d ago
ARGX
argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease
PremiumPress Releases
argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease
22d ago
ARGX
argenx Announces Annual General Meeting of Shareholders on May 7, 2024
PremiumPress Releases
argenx Announces Annual General Meeting of Shareholders on May 7, 2024
23d ago
ARGX
Argenx price target raised to $408 from $402 at Scotiabank
PremiumThe Fly
Argenx price target raised to $408 from $402 at Scotiabank
23d ago
ARGX
Argenx price target raised to $408 from $402 at Scotiabank
PremiumThe Fly
Argenx price target raised to $408 from $402 at Scotiabank
23d ago
ARGX
Argenx’s VYVGART Wins Approval in Japan for ITP
PremiumCompany AnnouncementsArgenx’s VYVGART Wins Approval in Japan for ITP
23d ago
6K
ARGX
Argenx announces MHLW approval of Vyvgart
PremiumThe Fly
Argenx announces MHLW approval of Vyvgart
23d ago
ARGX
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
PremiumPress Releases
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
23d ago
ARGX
Roche’s mixed myasthenia gravis data sending these stocks in opposite directions
PremiumThe Fly
Roche’s mixed myasthenia gravis data sending these stocks in opposite directions
28d ago
ARGX
IMVT
Roche’s mixed myasthenia gravis data sending these stocks in opposite directions
PremiumThe Fly
Roche’s mixed myasthenia gravis data sending these stocks in opposite directions
28d ago
ARGX
IMVT
Immunovant rallies after Chugai myasthenia gravis study failure
PremiumThe Fly
Immunovant rallies after Chugai myasthenia gravis study failure
28d ago
ARGX
IMVT
Argenx rallies after Chugai generalized myasthenia gravis study fails
PremiumThe Fly
Argenx rallies after Chugai generalized myasthenia gravis study fails
28d ago
ARGX
Argenx Highlights 2023 Achievements and Outlook
PremiumCompany AnnouncementsArgenx Highlights 2023 Achievements and Outlook
28d ago
6K
ARGX
Argenx price target raised to EUR 477 from EUR 465 at Morgan Stanley
PremiumThe Fly
Argenx price target raised to EUR 477 from EUR 465 at Morgan Stanley
1M ago
ARGX
argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting
PremiumPress Releases
argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting
1M ago
ARGX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >